Nuclear medicine uses small amounts of radioactive materials called radiotracers to evaluate organ function and tissue activity. Positron emission tomography (PET) scans help identify abnormal cellular activity, while other nuclear procedures provide information about various medical conditions. Because these imaging techniques reveal functional changes within the body, physicians use the findings to evaluate cancer and guide treatment planning. Here is more information on nuclear medicine’s role in personalized cancer treatment plans:
Explaining Nuclear Medicine Imaging
Nuclear medicine imaging uses small amounts of radioactive materials called radiotracers to evaluate organ function and tissue activity. Radiotracers may be administered through an injection, swallowed, or inhaled, depending on the procedure. Once administered, these materials travel through the body and accumulate in specific tissues or organs. Specialized imaging equipment detects the radiotracers, providing information about how different body systems function.
Different nuclear procedures use radiotracers selected for the tissues or organs being examined. Some radiotracers accumulate in bones, while others concentrate in the thyroid gland or other areas of the body. Because each procedure evaluates different biological processes, physicians select imaging methods based on the patient’s symptoms and medical history. A radiologist interprets the resulting images to identify abnormal activity and assist with diagnosis or treatment planning.
Detecting Cancer with PET
PET uses radioactive tracers to evaluate metabolic activity within organs and tissues. Cancer cells often demonstrate increased metabolic activity, which PET imaging may identify as areas of elevated tracer uptake. Because PET examines tissue function, it provides information that differs from structural imaging techniques such as CT scans.
Physicians use PET scans to evaluate certain cancers and determine whether abnormal activity appears in other areas of the body. PET imaging is sometimes combined with CT scanning, allowing physicians to compare metabolic findings with anatomical structures. These combined images provide information about tumor location and activity, while additional testing may be necessary to confirm findings.
PET scans also help physicians monitor how certain cancers respond to treatment. Changes in tracer uptake may indicate differences in tumor activity, although inflammation and other conditions also affect imaging results. Oncologists review these findings alongside other diagnostic information to evaluate treatment progress. When results suggest changes in disease activity, physicians may adjust treatment recommendations based on the patient’s overall condition.
Supporting Diagnoses Across Conditions
Nuclear medicine procedures evaluate different organs and biological processes to provide information about various medical conditions. Physicians select specific imaging studies based on symptoms and medical history, while radiotracers reveal patterns of organ function. Because these procedures examine different body systems, their findings help guide diagnostic evaluations and treatment planning. Common nuclear medicine procedures include:
- Evaluating bone conditions: Bone scans identify areas of abnormal bone activity associated with fractures, infections, arthritis, or certain cancers.
- Assessing gallbladder function: Hepatobiliary scans examine bile movement through the liver, gallbladder, and bile ducts to investigate possible abnormalities.
- Measuring gastric emptying: Gastric emptying studies evaluate how quickly food leaves the stomach, helping investigate nausea, vomiting, bloating, or abdominal discomfort.
- Examining kidney function: Nuclear medicine GFR studies measure kidney filtration activity and provide information about how effectively the kidneys process blood.
- Analyzing thyroid activity: Thyroid uptake scans measure radioactive iodine absorption to evaluate thyroid function and investigate conditions such as hyperthyroidism.
Personalizing Cancer Treatment Plans
Nuclear medicine imaging provides information about tumor activity and helps physicians evaluate certain cancers during treatment planning. PET scans reveal metabolic changes, while combined imaging techniques provide additional details about tumor location and surrounding tissues. Because cancer characteristics vary, oncologists review imaging findings alongside biopsy results, medical history, and other diagnostic information. Follow-up scans may reveal changes in tumor activity during treatment, helping physicians assess how the disease responds. These findings support decisions about surgery, radiation therapy, chemotherapy, or other treatment approaches.
Schedule Your Appointment Today
Nuclear medicine imaging provides information about organ function, tissue activity, and certain cancer-related changes. Physicians use these findings alongside other diagnostic results, while follow-up scans help evaluate changes during treatment. Because imaging needs vary between patients, healthcare providers recommend specific procedures based on medical history and treatment goals. Schedule a nuclear medicine imaging appointment today to complete your recommended evaluation and support ongoing treatment planning.